2,131
Views
14
CrossRef citations to date
0
Altmetric
Research Articles

Exposure to low-dose arsenic in early life alters innate immune function in children

, , , , , , , , , & show all
Pages 201-209 | Received 30 May 2019, Accepted 16 Aug 2019, Published online: 08 Nov 2019

References

  • Ahmed S, Akhtar E, Roy A, von Ehrenstein O, Vahter M, Wagatsuma Y, Raqib R. 2017. Arsenic exposure alters lung function and airway inflammation in children: A cohort study in rural Bangladesh. Environ Intl. 101:108–116.
  • Ahmed S, Moore S, Kippler M, Gardner R, Hawlader M, Wagatsuma Y, Raqib R, Vahter M. 2014. Arsenic exposure and cell-mediated immunity in pre-school children in rural Bangladesh. Toxicol Sci. 141(1):166–175.
  • Banerjee N, Banerjee S, Sen R, Bandyopadhyay A, Sarma N, Majumder P, Das J, Chatterjee M, Kabir S, Giri A. 2009. Chronic arsenic exposure impairs macrophage functions in the exposed individuals. J Clin Immunol. 29(5):582–594.
  • Bhavsar I, Miller C, Sabbagh M. 2015. Macrophage inflammatory protein (MIP)-1α/CCL3 as a biomarker. In Preedy V, and Patel V, editors. General methods in biomarker research and their applications. Biomarkers in disease: Methods, discoveries and applications. Dordrecht, Germany: Springer; p. 223–249.
  • Bishayi B, Sengupta M. 2003. Intracellular survival of Staphylococcus aureus due to alteration of cellular activity in arsenic- and lead-intoxicated mature Swiss albino mice. Toxicology. 184(1):31–39.
  • Biswas R, Ghosh P, Banerjee N, Das J, Sau T, Banerjee A, Roy S, Ganguly S, Chatterjee M, Mukherjee A. 2008. Analysis of T-cell proliferation and cytokine secretion in the individuals exposed to arsenic. Hum Exp Toxicol. 27(5):381–386.
  • Cardenas A, Smit E, Bethel J, Houseman E, Kile M. 2016. Arsenic exposure and the seropreva-lence of total hepatitis A antibodies in the US population: NHANES, 2003-2012. Epidemiol Infect. 144(8):1641–1651.
  • Cardenas A, Smit E, Houseman E, Kerkvliet N, Bethel J, Kile M. 2015. Arsenic exposure and prevalence of the varicella zoster virus in the United States: NHANES (2003-2004 and 2009-2010). Environ Health Perspect. 123(6):590–596.
  • Chen Y, Parvez F, Gamble M, Islam T, Ahmed A, Argos M, Graziano J, Ahsan H. 2009. Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: Review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol Appl Pharmacol. 239:184–192.
  • Coussens L, Werb Z. 2002. Inflammation and cancer. Nature. 420(6917):860–867.
  • de Onis M, Onyango A, Borghi E, Siyam A, Nishida C, Siekmann J. 2007. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 85(9):660–667.
  • DeAntonio R, Yarzabal J-P, Cruz JP, Schmidt JE, Kleijnen J. 2016. Epidemiology of community-acquired pneumonia and implications for vaccination of children living in developing and newly industrialized countries: A systematic literature review. Hum Vaccin Immunother. 12(9):2422–2440.
  • Dutta K, Prasad P, Sinha D. 2015. Chronic low level arsenic exposure evokes inflammatory responses and DNA damage. Intl J Hyg Environ Health. 218(6):564–574.
  • Ercoli G, Baddal B, Alessandra G, Marchi S, Petracca R, Arico B, Pizza M, Soriani M, Rossi-Paccani S. 2015. Development of a serological assay to predict antibody bactericidal activity against non-typeable Haemophilus influenzae. BMC Microbiol. 15:87.
  • Ferrario D, Gribaldo L, Hartung T. 2016. Arsenic exposure and immunotoxicity: A review including the possible influence of age and sex. Curr Environ Health Rep. 3(1):1–12.
  • Gordon S, Irving G, Lawson R, Lee M, Read R. 2000. Intracellular trafficking and killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by opsonins. Infect Immun. 68(4):2286–2293.
  • Górska K, Paplińska-Goryca M, Nejman-Gryz P, Goryca K, Krenke R. 2017. Eosinophilic and neutrophilic airway inflammation in the phenotyping of mild-to-moderate asthma and chronic obstructive pulmonary disease. Copd. 14(2):181–189.
  • Hall SL, Baker T, Lajoie S, Richgels PK, Yang Y, McAlees JW, van Lier A, Wills-Karp M, Sivaprasad U, Acciani TH, et al. 2017. IL-17A enhances IL-13 activity by enhancing IL-13-induced signal transducer and activator of transcription-6 activation. J Allergy Clin Immunol. 139(2):462–471.
  • Hegedus CM, Skibola CF, Warner M, Skibola DR, Alexander D, Lim S, Dangleben NL, Zhang L, Clark M, Pfeiffer RM, et al. 2008. Decreased urinary β-defensin-1 expression as a biomarker of response to arsenic. Toxicol Sci. 106(1):74–82.
  • Huhmann B, Harvey C, Navas-Acien A, Graziano J, Parvez F, Chen Y, Argos M, Ahmed A, Hasan A, Ahsan H, et al. 2019. Changes in arsenic exposure in Araihazar, Bangladesh from 2001 through 2015 following a blanket well testing and education campaign. Environ Int. 125:82–89.
  • Islam L, Zahid M, Nabi A, Hossain M. 2012. Function of serum complement in drinking water arsenic toxicity. J Toxicol. 2012:302817.
  • Jang M, Sahastrabuddhe S, Yun C, Han S, Yang J. 2016. Serum bactericidal assay for evaluation of typhoid vaccine using a semi-automated colony-counting method. Microb Pathogen. 97:19–26.
  • Jiang Y, Xiao W, Zhu M, Yang Z, Pan X, Zhang Y, Sun C, Xing Y. 2012. The effect of human antibacterial peptide LL-37 in the pathogenesis of chronic obstructive pulmonary disease. Respir Med. 106(12):1680–1689.
  • Leepiyasakulchai C, Ignatowicz L, Pawlowski A, Kallenius G, Skold M. 2012. Failure to recruit anti-inflammatory CD103+ dendritic cells and a diminished CD4+Foxp3+ regulatory T-cell pool in mice that display excessive lung inflammation and increased susceptibility to Mycobac-terium tuberculosis. Infect Immun. 80(3):1128–1139.
  • Lemarie A, Morzadec C, Bourdonnay E, Fardel O, Vernhet L. 2006. Human macrophages constitute targets for immunotoxic inorganic arsenic. J Immunol. 177(5):3019–3027.
  • Liu W, Jiang L, Bian C, Liang Y, Xing R, Yishakea M, Dong J. 2016. Role of CX3CL1 in diseases. Arch Immunol Ther Exp. 64(5):371–383.
  • Mannan T, Ahmed S, Akhtar E, Ahsan K, Haq A, Kippler M, Vahter M, Raqib R. 2018. Associations of arsenic exposure with telomere length and naïve T-cells in childhood-A birth cohort study. Toxicol Sci. 164(2):539–549.
  • Martin-Chouly C, Morzadec C, Bonvalet M, Galibert M, Fardel O, Vernhet L. 2011. Inorganic arsenic alters expression of immune and stress response genes in activated primary human T-lymphocytes. Mol Immunol. 48(6–7):956–965.
  • Newcomb D, Boswell M, Huckabee M, Goleniewska K, Dulek D, Reiss S, Lukacs N, Kolls J, Peebles R. 2012. IL-13 regulates TH17 secretion of IL-17A in an IL-10-dependent manner. J Immunol. 188(3):1027–1035.
  • Olivas-Calderon E, Recio-Vega R, Gandolfi A, Lantz R, Gonzalez-Cortes T, Gonzalez-De Alba C, Froines J, Espinosa-Fematt J. 2015. Lung inflammation biomarkers and lung function in children chronically exposed to arsenic. Toxicol Appl Pharmacol. 287(2):161–167.
  • Parvez F, Chen Y, Brandt-Rauf PW, Bernard A, Dumont X, Slavkovich V, Argos M, D’Armiento J, Foronjy R, Hasan MR, et al. 2008. Non-malignant respiratory effects of chronic arsenic exposure from drinking water among never-smokers in Bangladesh. Environ Health Perspect. 116(2):190–195.
  • Parvez F, Lauer F, Factor-Litvak P, Liu X, Santella R, Islam T, Eunus M, Alam N, Sarwar G, Rahman M, et al. 2019. Assessment of arsenic and polycyclic aromatic hydrocarbon (PAH) exposures on immune function among males in Bangladesh. PLoS One. 14(5):e0216662
  • Persson L, Anerud M, Hardie J, Miodini Nilsen R, Bakke P, Eagan T, Hiemstra P. 2017. Anti-microbial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease. Eur Respir J. 49:3.
  • Rahman A, Granberg C, Persson L. 2017. Early life arsenic exposure, infant and child growth, and morbidity: A systematic review . Arch Toxicol. 91(11):3459–3467.
  • Rahman M, Sarker P, Roy S, Ahmad S, Chisti J, Azim T, Mathan M, Sack D, Andersson J, Raqib R. 2005. Effects of zinc supplementation as adjunct therapy on the systemic immune responses in shigellosis. Am J Clin Nutr. 81(2):495–502.
  • Rahman M, Sohel N, Yunus F, Alam N, Nahar Q, Streatfield P, Yunus M. 2019. Arsenic exposure and young adult's mortality risk: A 13-year follow-up study in Matlab, Bangladesh. Environ Int. 123:358–367.
  • Raqib R, Ahmed S, Ahsan K, Kippler M, Akhtar E, Roy A, Lu Y, Arifeen S, Wagatsuma Y, Vahter M. 2017. Humoral immunity in arsenic-exposed children in rural Bangladesh: Total immunoglobulins and vaccine-specific antibodies. Environ Health Perspect. 125(6):067006.
  • Raqib R, Ahmed S, Sultana R, Wagatsuma Y, Mondal D, Hoque A, Nermell B, Yunus M, Roy S, Persson L, et al. 2009. Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol Lett. 185(3):197–202.
  • Saha A, Chowdhury M, Nazim M, Alam M, Ahmed T, Hossain M, Hore S, Sultana G, Svennerholm A, Qadri F. 2013. Vaccine-specific immune response to an inactivated oral cholera vaccine and EPI vaccines in a high and low arsenic area in Bangladeshi children. Vaccine. 31(4):647–652.
  • Sanchez T, Perzanowski M, Graziano J. 2016. Inorganic arsenic and respiratory health, from early life exposure to sex-specific effects: A systematic review. Environ Res. 147:537–555.
  • Sengupta M, Bishayi B. 2002. Effect of lead and arsenic on murine macrophage response. Drug Chem Toxicol. 25(4):459–472.
  • Serody J, Burkett S, Panoskaltsis-Mortari A, Ng-Cashin J, McMahon E, Matsushima G, Lira S, Cook D, Blazar B. 2000. T-Lymphocyte production of macrophage inflammatory protein-1α is critical to the recruitment of CD8+ T-cells to the liver, lung, and spleen during graft-vs-host disease. Blood. 96(9):2973–2980.
  • Shearer W, Easley K, Goldfarb J, Jenson H, Rosenblatt H, Kovacs A, McIntosh K, Group PCHS. 2000. Evaluation of immune survival factors in pediatric HIV-1 infection. Ann NY Acad Sci. 918:298–312.
  • Shimanovich A, Buskirk A, Heine S, Blackwelder W, Wahid R, Kotloff K, Pasetti M. 2017. Functional and antigen-specific serum antibody levels as correlates of protection against shigellosis in a controlled human challenge study. Clin Vaccine Immunol. 24(2):e00412–16.
  • Thomi R, Schlapbach C, Yawalkar N, Simon D, Yerly D, Hunger R. 2018. Elevated levels of the anti-microbial peptide LL-37 in hidradenitis suppurativa are associated with a TH1/TH17 immune response. Exp Dermatol. 27(2):172–177.
  • Tseng C. 2009. A review on environmental factors regulating arsenic methylation in humans. Toxicol Appl Pharmacol. 235(3):338–350.
  • Vahter M. 2002. Mechanisms of arsenic biotransformation. Toxicology. 181:211–217.
  • van Geen A, Cheng Z, Jia Q, Seddique A, Rahman M, Rahman M, Ahmed K. 2007. Monitoring 51 community wells in Araihazar, Bangladesh, for up to 5 years: Implications for arsenic mitigation. J Environ Sci Health A. 42(12):1729–1740.
  • van Harten R, van Woudenbergh E, van Dijk A, Haagsman H. 2018. Cathelicidins: Immunomodulatory anti-microbials. Vaccines. 6(3):63.
  • Xu H, Lauer F, Liu K, Hudson L, Burchiel S. 2016. Environmentally relevant concentrations of arsenite and monomethylarsonous acid inhibit IL-7/STAT5 cytokine signaling pathways in mouse CD3+CD4-CD8- double negative thymus cells. Toxicol Lett. 247:62–68.
  • Yang Y, Guo Y, Zhang H, Sun T. 2015. Anti-microbial peptide LL-37 circulating levels in chronic obstructive pulmonary disease patients with high risk of frequent exacerbations. J Thorac Dis. 7:740–745.
  • Yu S, Liao W, Lee C, Chai C, Yu C, Yu H. 2018. Immunological dysfunction in chronic arsenic exposure: From subclinical condition to skin cancer. J Dermatol. 45(11):1271–1277.